Transcriptomics

Dataset Information

0

Siponimod modulates the reaction of microglial cells to pro-inflammatory stimulation


ABSTRACT: Siponimod (Mayzent®), a sphingosine 1-phosphate receptor (S1PR) modulator which prevents lymphocyte egress from lymphoid tissues, is approved for the treatment of relapsing-remitting- and active secondary progressive multiple sclerosis. It can cross the blood-brain-barrier (BBB) and selectively binds to S1PR1 and S1PR5 expressed by several cell populations of the central nervous system (CNS) including microglia. To investigate wether Siponimod modulates the genetic signature of inflammed microglia, we performed a transcriptome analyses of primary rat microglial cells stimulated with LPS and With or Without Siponimod.

ORGANISM(S): Rattus norvegicus

PROVIDER: GSE216804 | GEO | 2022/11/02

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-06-27 | GSE270373 | GEO
2024-06-05 | GSE268826 | GEO
2024-02-21 | GSE221482 | GEO
2015-09-02 | GSE70795 | GEO
2023-01-15 | GSE165000 | GEO
2015-09-17 | GSE70363 | GEO
2011-04-16 | E-GEOD-28642 | biostudies-arrayexpress
2017-09-10 | GSE61240 | GEO
2024-11-07 | E-MTAB-14469 | biostudies-arrayexpress
2015-09-02 | E-GEOD-70795 | biostudies-arrayexpress